Patent details

Basic Information

Publication number:

EP1126841

PCT Application Number:

PCT/US/1999/025388

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP999601719

PCT Publication Number:

WO/2000/025779

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

COMBINATIONS OF A 5HT1B/1D AGONIST AND A SELECTIVE COX-2 INHIBITOR FOR THE TREATMENT OF MIGRAINE

French Title of Invention:

COMBINAISONS D'UNE AGONISTE 5HT1B/1D ET D'UN INHIBITEUR SELECTIVE DE COX-2 DESTINEES AU TRAITEMENT DE MIGRAINE

German Title of Invention:

ZUSAMMENSETZUNGEN AUS EINEM 5HT1B/1D AGONISTEN UND EINEM SELEKTIVEN COX-2 HEMMER ZUR BEHANDLUNG VON MIGRÄNE

SPC Number:

Dates

Filing date:

29/10/1999

Grant date:

15/12/2004

EP Publication Date:

15/12/2004

PCT Publication Date:

11/05/2000

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

29/08/2001

EP B1 Publication Date:

15/12/2004

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

29/10/2005

Expiration date:

29/10/2019

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

29/10/1999

 

 

Name:

Merck & Co. Inc.

Address:

126 East Lincoln Avenue, Rahway, New Jersey 07065-0907, United States (US)

Inventor

1

Name:

SANDQUIST Eric, J.

Address:

United States (US)

2

Name:

HARGREAVES Richard

Address:

United States (US)

3

Name:

KHANNA Deepak, K.

Address:

United States (US)

4

Name:

REINES Scott, A.

Address:

United States (US)

5

Name:

SIMITCHIEVA Kremena

Address:

United States (US)

6

Name:

MCKINNEY Errol

Address:

United States (US)

Priority

Priority Number:

106605 P

Priority Date:

02/11/1998

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 31/405;

Filing date	Document type	Number of pages